Extra Space Storage (EXR) Market Value Declined While Adelante Capital Management Trimmed Its Holding; Broadfin Capital Cut Idera Pharmaceuticals (IDRA) Position by $2.85 Million

February 21, 2018 - By Kurt Siggers

Kevin Kotler decreased its stake in Idera Pharmaceuticals Inc (IDRA) by 36.93% based on its latest 2017Q3 regulatory filing with the SEC. Broadfin Capital Llc sold 1.42M shares as the company’s stock declined 1.15% while stock markets rallied. The hedge fund run by Kevin Kotler held 2.43M shares of the health care company at the end of 2017Q3, valued at $5.42M, down from 3.85 million at the end of the previous reported quarter. Broadfin Capital Llc who had been investing in Idera Pharmaceuticals Inc for a number of months, seems to be less bullish one the $381.49M market cap company. The stock increased 1.04% or $0.02 during the last trading session, reaching $1.95. About 1.80M shares traded. Idera Pharmaceuticals, Inc. (NASDAQ:IDRA) has risen 21.13% since February 21, 2017 and is uptrending. It has outperformed by 4.43% the S&P500.

Adelante Capital Management Llc decreased its stake in Extra Space Storage Inc (EXR) by 26.54% based on its latest 2017Q3 regulatory filing with the SEC. Adelante Capital Management Llc sold 221,721 shares as the company’s stock declined 0.98% while stock markets rallied. The hedge fund held 613,599 shares of the real estate investment trusts company at the end of 2017Q3, valued at $49.04 million, down from 835,320 at the end of the previous reported quarter. Adelante Capital Management Llc who had been investing in Extra Space Storage Inc for a number of months, seems to be less bullish one the $10.63B market cap company. The stock decreased 1.76% or $1.45 during the last trading session, reaching $80.75. About 1.23 million shares traded or 14.42% up from the average. Extra Space Storage Inc. (NYSE:EXR) has declined 14.77% since February 21, 2017 and is downtrending. It has underperformed by 31.47% the S&P500.




Since August 21, 2017, it had 0 insider purchases, and 6 sales for $3.51 million activity. OVERTURF JAMES sold $106,337 worth of Extra Space Storage Inc. (NYSE:EXR) on Wednesday, October 18.

Among 16 analysts covering Extra Space Storage Inc. (NYSE:EXR), 4 have Buy rating, 1 Sell and 11 Hold. Therefore 25% are positive. Extra Space Storage Inc. had 50 analyst reports since July 23, 2015 according to SRatingsIntel. The stock has “Buy” rating by Robert W. Baird on Monday, October 16. As per Friday, August 12, the company rating was downgraded by Raymond James. The firm has “Sector Perform” rating given on Tuesday, January 3 by RBC Capital Markets. The firm earned “Neutral” rating on Friday, July 29 by DA Davidson. The rating was downgraded by Morgan Stanley on Tuesday, December 13 to “Underweight”. As per Friday, June 9, the company rating was maintained by Jefferies. The rating was maintained by KeyBanc Capital Markets on Wednesday, October 11 with “Hold”. BMO Capital Markets maintained the shares of EXR in report on Thursday, March 23 with “Hold” rating. The firm has “Hold” rating given on Tuesday, September 8 by Evercore. The stock has “Hold” rating by Jefferies on Monday, November 27.

Investors sentiment decreased to 1.19 in 2017 Q3. Its down 0.02, from 1.21 in 2017Q2. It turned negative, as 25 investors sold EXR shares while 117 reduced holdings. 41 funds opened positions while 128 raised stakes. 131.25 million shares or 0.15% less from 131.45 million shares in 2017Q2 were reported. Creative Planning invested 0% in Extra Space Storage Inc. (NYSE:EXR). Geode Cap Ltd Liability Corp has invested 0.04% in Extra Space Storage Inc. (NYSE:EXR). State Street Corp invested 0.05% of its portfolio in Extra Space Storage Inc. (NYSE:EXR). Capital Mngmt Corp Va invested in 0.2% or 8,850 shares. Ubs Asset Americas reported 611,090 shares. Kemper Corporation Master Retirement Trust accumulated 4,875 shares. Mason Street Advsrs Ltd Liability Co stated it has 0.03% of its portfolio in Extra Space Storage Inc. (NYSE:EXR). Chesley Taft And Assocs Ltd Liability Com holds 0.06% or 7,975 shares in its portfolio. Ww Asset Management holds 13,483 shares or 0.04% of its portfolio. Aperio Grp Incorporated Ltd Liability Company reported 43,447 shares stake. Lpl Fin accumulated 14,430 shares. Moreover, Fisher Asset Mgmt has 0.02% invested in Extra Space Storage Inc. (NYSE:EXR) for 219,985 shares. 38,973 are owned by Td Asset Management Incorporated. 2,864 were accumulated by Brinker Cap. Guardian Life Insurance Communication Of America has 283 shares for 0% of their portfolio.

Adelante Capital Management Llc, which manages about $1.78 billion and $1.81B US Long portfolio, upped its stake in Ddr Corp. (NYSE:DDR) by 232,175 shares to 916,540 shares, valued at $8.40M in 2017Q3, according to the filing. It also increased its holding in Highwoods Properties Inc. (NYSE:HIW) by 51,253 shares in the quarter, for a total of 779,958 shares, and has risen its stake in Equity Residential (NYSE:EQR).

Broadfin Capital Llc, which manages about $1.26B and $676.01 million US Long portfolio, upped its stake in Iovance Biotherapeutics Inc by 211,263 shares to 2.49M shares, valued at $19.28M in 2017Q3, according to the filing. It also increased its holding in Nuvasive Inc (NASDAQ:NUVA) by 32,100 shares in the quarter, for a total of 88,000 shares, and has risen its stake in Endo Intl Plc (NASDAQ:ENDP).

Analysts await Idera Pharmaceuticals, Inc. (NASDAQ:IDRA) to report earnings on March, 21. They expect $-0.08 earnings per share, down 900.00% or $0.09 from last year’s $0.01 per share. After $-0.10 actual earnings per share reported by Idera Pharmaceuticals, Inc. for the previous quarter, Wall Street now forecasts -20.00% EPS growth.

Among 4 analysts covering Idera Pharma (NASDAQ:IDRA), 4 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Idera Pharma had 7 analyst reports since January 6, 2016 according to SRatingsIntel. The stock of Idera Pharmaceuticals, Inc. (NASDAQ:IDRA) has “Outperform” rating given on Wednesday, February 1 by Wedbush. The firm has “Buy” rating by Piper Jaffray given on Monday, September 11. The firm has “Buy” rating by H.C. Wainwright given on Thursday, November 16. On Thursday, November 9 the stock rating was maintained by Piper Jaffray with “Buy”. Wedbush initiated Idera Pharmaceuticals, Inc. (NASDAQ:IDRA) rating on Wednesday, January 6. Wedbush has “Outperform” rating and $6.0 target.

Investors sentiment decreased to 1.36 in 2017 Q3. Its down 0.10, from 1.46 in 2017Q2. It turned negative, as 5 investors sold IDRA shares while 20 reduced holdings. 11 funds opened positions while 23 raised stakes. 46.97 million shares or 1.60% more from 46.23 million shares in 2017Q2 were reported. Citadel Advsr Llc reported 23,050 shares. 42,712 were accumulated by Guggenheim Capital. Blackrock invested in 6.52M shares. Credit Suisse Ag holds 0% or 72,576 shares. Tci Wealth Advisors stated it has 0% of its portfolio in Idera Pharmaceuticals, Inc. (NASDAQ:IDRA). Private Advisor Grp Lc owns 27,000 shares. Deutsche Savings Bank Ag owns 96,675 shares. Schwab Charles Investment Mgmt has 0% invested in Idera Pharmaceuticals, Inc. (NASDAQ:IDRA). Northern Trust has 0% invested in Idera Pharmaceuticals, Inc. (NASDAQ:IDRA) for 1.25M shares. Leavell Invest Mngmt holds 0.02% of its portfolio in Idera Pharmaceuticals, Inc. (NASDAQ:IDRA) for 81,271 shares. 11,247 were reported by National Bank & Trust Of America Corp De. Gsa Cap Ptnrs Limited Liability Partnership holds 256,688 shares. Point72 Asset Mngmt LP accumulated 400,000 shares or 0% of the stock. Mycio Wealth Prns Ltd Limited Liability Company has 0.06% invested in Idera Pharmaceuticals, Inc. (NASDAQ:IDRA). Commonwealth Equity Svcs reported 54,700 shares.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.